Contact
searchSearch
HMP Global

Insights

Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
New Data Emerges for Managing Type 2 Diabetes
10/06/2022
Dr Jennings explores research comparing the efficacy of several SGLT2 inhibitors as second-line therapy options for patients with type 2 diabetes who have been treated with metformin.
Dr Jennings explores research comparing the efficacy of several SGLT2 inhibitors as second-line therapy options for patients with type 2 diabetes who have been treated with metformin.
Dr Jennings explores research...
10/06/2022
Pharmacy Learning Network
Save Those Kidney Beans: Nephro-Protective Effects of SGLT2 Inhibitors
Commentary
Save Those Kidney Beans: Nephro-Protective Effects of SGLT2 Inhibitors
05/05/2021
In this week’s issue of Talking Therapeutics, Dr Jennings explores a new drug approval and what it means for patients with chronic kidney disease.
In this week’s issue of Talking Therapeutics, Dr Jennings explores a new drug approval and what it means for patients with chronic kidney disease.
In this week’s issue of Talking...
05/05/2021
Pharmacy Learning Network
Predicting the Need for SGLT2 Inhibitors for Future Heart Failure
Commentary
Predicting the Need for SGLT2 Inhibitors for Future Heart Failure
02/23/2021
“The SGLT2i are an expensive group of drugs in comparison to other goal-directed medical therapies for HfrEF, says Mark Munger, PharmD. “Perhaps this data might assist in formulary decisions and oversight use of these medications.”
“The SGLT2i are an expensive group of drugs in comparison to other goal-directed medical therapies for HfrEF, says Mark Munger, PharmD. “Perhaps this data might assist in formulary decisions and oversight use of these medications.”
“The SGLT2i are an expensive...
02/23/2021
Pharmacy Learning Network
Commentary
The Expanding Clinical Benefits Linked With Metformin Use: New Study Provides More Data Suggesting Metformin is Associated With Reduced COVID-19 Mortality Rates
02/02/2021
“Research indicates that metformin may exert the various clinical effects via different signaling pathways; however, the precise mechanisms have not yet been determined and research is ongoing,” says Yvette C. Terrie, BS Pharm, RPh,...
“Research indicates that metformin may exert the various clinical effects via different signaling pathways; however, the precise mechanisms have not yet been determined and research is ongoing,” says Yvette C. Terrie, BS Pharm, RPh,...
“Research indicates that...
02/02/2021
Pharmacy Learning Network
Advanced DNA-Based Medicine May Offer Lasting Pain Relief in Diabetic Peripheral Neuropathy
Commentary
Advanced DNA-Based Medicine May Offer Lasting Pain Relief in Diabetic Peripheral Neuropathy
01/13/2021
Sunyoung Kim, CEO, and William K. Schmidt, senior vice president, Clinical Development, Helixmith Co, Ltd, discuss a non-viral plasmid DNA-based medicine that, when injected into muscles, stimulates the synthesis of twin proteins that are, in...
Sunyoung Kim, CEO, and William K. Schmidt, senior vice president, Clinical Development, Helixmith Co, Ltd, discuss a non-viral plasmid DNA-based medicine that, when injected into muscles, stimulates the synthesis of twin proteins that are, in...
Sunyoung Kim, CEO, and William...
01/13/2021
Pharmacy Learning Network
Commentary
Implementing Patient Education Strategies to Help Patients in Reducing or Preventing the Incidence of Prediabetes, Type 2 Diabetes
08/04/2020
As frontline health care providers, pharmacists are in a pivotal position to act as patient identifiers, patient educators and patient advocates especially for those at risk for or with diabetes.
As frontline health care providers, pharmacists are in a pivotal position to act as patient identifiers, patient educators and patient advocates especially for those at risk for or with diabetes.
As frontline health care...
08/04/2020
Pharmacy Learning Network
Barriers to Diabetes Treatment Linked With Increased Monthly Costs
Interview
Barriers to Diabetes Treatment Linked With Increased Monthly Costs
03/25/2020
Tayla Rose, PharmD, MEd, RPh, BCACP, CDE, assistant clinical professor in the Department of Pharmacy and Health Systems Sciences at Northeastern University School of Pharmacy, explains why providers should be mindful of the high cost of...
Tayla Rose, PharmD, MEd, RPh, BCACP, CDE, assistant clinical professor in the Department of Pharmacy and Health Systems Sciences at Northeastern University School of Pharmacy, explains why providers should be mindful of the high cost of...
Tayla Rose, PharmD, MEd, RPh,...
03/25/2020
Pharmacy Learning Network
Improved Reimbursement Options Needed for National Diabetes Prevention Program Providers
Interview
Improved Reimbursement Options Needed for National Diabetes Prevention Program Providers
03/17/2020
Jennifer Torres Mosst, PhD, program manager of Diabetes Strategies at the Division of Chronic Disease and Injury Prevention, explain why billing and reimbursement approaches play a critical role in the types of programs that can be...
Jennifer Torres Mosst, PhD, program manager of Diabetes Strategies at the Division of Chronic Disease and Injury Prevention, explain why billing and reimbursement approaches play a critical role in the types of programs that can be...
Jennifer Torres Mosst, PhD,...
03/17/2020
First Report Managed Care
Among Diabetes Patients, Cost Increases Linked With Guideline Non-Compliance
Interview
Among Diabetes Patients, Cost Increases Linked With Guideline Non-Compliance
03/10/2020
Swapnil Rajpathak, executive director cardiometabolic team, Center for Observational Real World Evidence, Merck & Co, Inc, discusses the importance of adherence to evidence-based care guidelines to improve health outcomes and reduce costs.
Swapnil Rajpathak, executive director cardiometabolic team, Center for Observational Real World Evidence, Merck & Co, Inc, discusses the importance of adherence to evidence-based care guidelines to improve health outcomes and reduce costs.
Swapnil Rajpathak, executive...
03/10/2020
First Report Managed Care
Limiting Major CVD Events With Metformin in Vets With Diabetes, Reduced Kidney Function
Interview
Limiting Major CVD Events With Metformin in Vets With Diabetes, Reduced Kidney Function
03/02/2020
Christianne Roumie, MD, MPH, associate professor of Internal Medicine and Pediatrics at Vanderbilt University Medical Center and the VA Tennessee Valley Healthcare System, discusses the benefits of the diabetes medication metformin on...
Christianne Roumie, MD, MPH, associate professor of Internal Medicine and Pediatrics at Vanderbilt University Medical Center and the VA Tennessee Valley Healthcare System, discusses the benefits of the diabetes medication metformin on...
Christianne Roumie, MD, MPH,...
03/02/2020
Veterans Health Today

What's Trending?

News
New Screening Tool Helps Identify Sleep Apnea in Patients With Epilepsy
10/25/2018
Detecting and treating obstructive sleep apnea in people with epilepsy might help them maintain seizure control.
Detecting and treating obstructive sleep apnea in people with epilepsy might help them maintain seizure control.
Detecting and treating...
10/25/2018
Annals of Long-Term Care
News
Oral THC Fails to Ease Behavioral Symptoms of Dementia
05/13/2015
Oral tetrahydrocannabinol, the main active ingredient in marijuana, did not reduce neuropsychiatric symptoms in patients with dementia enrolled in a randomized controlled trial.
Oral tetrahydrocannabinol, the main active ingredient in marijuana, did not reduce neuropsychiatric symptoms in patients with dementia enrolled in a randomized controlled trial.
Oral tetrahydrocannabinol, the...
05/13/2015
Pharmacy Learning Network
News
Worries About Using Plavix With Heartburn Pills May Be Overblown
10/07/2010
10/07/2010
First Report Managed Care
Identifying Spending Patterns Using Data-Driven Approaches
Interview
Identifying Spending Patterns Using Data-Driven Approaches
11/12/2020
Julie C Lauffenburger, PharmD, PhD, Brigham and Women’s Hospital, discusses her recent study that examined data-driven models to predict spending patterns, and she highlights how health care organizations may find this application of...
Julie C Lauffenburger, PharmD, PhD, Brigham and Women’s Hospital, discusses her recent study that examined data-driven models to predict spending patterns, and she highlights how health care organizations may find this application of...
Julie C Lauffenburger, PharmD,...
11/12/2020
First Report Managed Care
News
Fewer liver cancers in HBV patients on long-term entecavir
07/06/2016
By Will Boggs MDNEW YORK (Reuters Health) -...
By Will Boggs MDNEW YORK (Reuters Health) -...
...
07/06/2016
Population Health

Stay Informed—Sign up today!

Population Health Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use